Corton Capital’s RxSight RXST Stock Holding History

Corton Capital’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-4,714	Closed	-$233K	–	603
2024 Q3	$233K	Buy	+4,714	New	+$242K	0.11%	304

Other funds holding RXST

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Corton Capital's RXST Position: Q4 2024 in Review

Corton Capital sold out of RxSight (RXST) in Q4 2024, closing a stake of 4,714 shares — an estimated $233K sold.

Corton Capital first reported a position in RXST in Q3 2024 and held it in 1 quarter. The position peaked at $233K in Q3 2024. 212 funds tracked by Wall St. Rank hold RXST as of Q4 2024.

Corton Capital reported no remaining RxSight position as of Q4 2024 after selling out during the quarter.
Corton Capital sold 4,714 RxSight shares in Q4 2024, an estimated $233K.
Corton Capital first reported a position in RxSight in Q3 2024 and held it in 1 quarter.
Corton Capital's RxSight position peaked at $233K in Q3 2024.
212 funds tracked by Wall St. Rank held RxSight as of Q4 2024.

Based on Corton Capital's 13F filing for Q4 2024, filed 14 Feb 2025.